ema tirzepatide EU regulator recommends expanding Mounjaro approval to obesity Agenzia europea dei medicinali (Ema):

Its bacosides have several effects on the nervous system: They boost neuronal communication by enhancing the growth of nerve endings (dendrites), which may improve synaptic transmission

GLP-1 receptors may be able to help with this cycle by dampening the release of dopamine

It's best to consult your healthcare provider for limits

Why People Wont Quit a Weight Loss DrugEven When It Makes Them Feel Sick Rutgers Health research sheds light on why people using the anti-obesity medication semaglutide say the results matter more than the side effects Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as effective, even when facing unpleasant side effects, according to Rutgers Health researchers

Thats because circadian rhythm, the bodys natural clock, also plays a role in the timing of GLP-1 secretion